保健所のしごとメモ

保健所のしごとに関するメモやリンク集です

保健所医師とは

国保健所長会 

www.phcd.jp

保健所医師(公衆衛生医師)の情報が載っています。

保健所の業務紹介 パンフレット 2020年版

ブログアイキャッチ結核対策も載っています。

https://www.phcd.jp/02/j_ishiboshu/pdf/panf_2020.pdf

 

期待の若手シリーズ

公衆衛生医師となった方のエッセイ。月刊「公衆衛生情報」掲載。

https://www.phcd.jp/02/j_koushueisei/index.html#watashi

 

その他

日々の業務についてのブログ


全国の保健所の様子がわかります。
保健所長のお仕事紹介〜現役公衆衛生医師のホンネに迫る〜

 

公衆衛生医師の紹介動画

www.youtube.com

 

 

Ref. the tragic fallacy of global health reform 2025.09_Lancet

www.thelancet.com

 

Offline: The tragic fallacy of global health reform
Richard Horton Send email to richard.horton@lancet.com

In Jorge Luis Borges's fantastical short story, Tlön, Uqbar, Orbis Tertius, written in 1940, he imagines the invention of a new world, Tlön, by a secret society of, among others, astronomers, biologists, and engineers. 

 

Two important reform initiatives emerged. First, the Accra Reset, launched by Ghana's President John Mahama during the 2025 UN General Assembly, intends to end the political marginalisation aid recipients endured, where rules and instruments that shaped global health excluded the nations those same rules and instruments claimed to be serving.

1つめとしてアクラリセット(援助を受ける側の国が議論の辺縁にいる状態をやめること)

 

Second, WHO is hosting its own reform process—“a time-bound multilateral effort to support transformation of global health architecture”. A report on what this reform might look like is being prepared for the 2027 World Health Assembly by WHO's Director-General. 

2つめとして多国間による共同サポート

 

What is sometimes forgotten is that global health is about power—and the rich world, despite its kindly reassurances, will not loosen the ties that keep countries constrained and dependent. And remember: reform has been a subject for rumination ever since global health entered our lexicon.

Councils, panels, and task forces will thrive and reproduce. And this vast displacement activity will likely contribute not one trace of benefit to the health of peoples.

このままでは誰の得にもならないのではないか。

Ref. Dr.Ukai Asymptomatic TB in Japan Lancet.RHWP_2026.05

https://www.sciencedirect.com/science/article/pii/S2666606526000842

 

www.thelancet.com

Articles Volume 70101880 May 2026
Open access

Download Full Issue
Asymptomatic tuberculosis in Japan: a 15-year national surveillance study, 2008–2022
Tomohiko Ukaia Send email to ukai_tomohiko@jata.or.jp ∙ Kaung Si Thua ∙ Kazuhiro Uchimuraa ∙ Akihiro Ohkadoa ∙ Takashi Yoshiyamaa,b ∙ Edine Tiemersmac

 

Background

Asymptomatic tuberculosis (TB), defined as active TB without reported symptoms, remains poorly characterised. We assessed long-term trends, factors associated with asymptomatic diagnosis, and treatment outcomes of asymptomatic TB in Japan using nationwide surveillance data with widespread chest radiographic screening.
 

Findings

Among 141,481 pulmonary TB cases, 20.2% were asymptomatic, 61.3% had respiratory symptoms, and 18.5% had non-respiratory symptoms. Over time, the proportion of asymptomatic TB increased slightly, remaining around one-fifth of all pulmonary TB cases and 12–15% of cases with smear-positive or cavitary disease. Among asymptomatic patients, 34.1% were smear positive and 20.3% had cavitary disease. In multivariable analysis, asymptomatic TB was more common in younger groups, those in employment or education, and those with previous TB treatment. Mortality during treatment was lower in asymptomatic TB (adjusted risk ratio 0.57, 95% CI 0.54–0.60) than in respiratory symptomatic TB.

Ref. Expanding Xpert test TB+HIV Lancet.ID_2026.09

www.thelancet.com

Articles Volume 26, Issue 9 p881-893 September 2026
Open access

Download Full Issue
Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trial

タンザニアとモザンビークの11の病院で実施されました。入院後24時間以内に、結核の既往歴や最近の結核治療歴のないHIV感染成人(18歳以上)を連続的に登録しました。介入群は、症状の有無にかかわらず、喀痰、便、尿からのXpert MTB/RIF Ultra(Xpert Ultra)検査と、ラテラルフロー尿リポアラビノマンナン(LF-LAM)検査(Determine TB LAM Agアッセイ)を受けました。対照群は、WHOが推奨する症状に基づく標準的な喀痰Xpert UltraおよびLF-LAM検査を受けました。主要評価項目は、微生物学的に結核と確定診断された参加者のうち、72時間以内に治療を開始した者の割合でした。

 

調査結果

2022年9月25日から2024年3月15日まで、1534人の参加者をスクリーニングし、1172人(76.6%)を介入群(n=582)または対照群(n=590)にランダムに割り当てました。入院時、参加者のうち715人(61.0%)が女性で、845人(75.4%)が抗レトロウイルス療法(ART)を受けており、CD4細胞数の中央値は1μLあたり232細胞(IQR 87~490)でした。対照群では、505人(85.6%)が結核に合致する症状があり、喀痰Xpert Ultra検査の対象となり(そのうち306人[60.6%]が検体を提供)、538人(91.2%)がWHOのLF-LAM検査基準を満たしていました。治療意図分析では、介入群の参加者582人のうち93人(16.0%)、対照群の参加者590人のうち90人(15.3%)が微生物学的に結核と診断され、72時間以内に治療を開始した(差0.7%、95%信頼区間-3.4~4.8、p=0.73)。8週間の全死因死亡率は、介入群で25.8%(582人中150人)、対照群で28.8%(590人中170人)であった(ハザード比0.86、95%信頼区間0.69~1.07、p=0.18)。結核治療開始までの期間の中央値は、介入群で0.98日(四分位範囲0.83~1.92)、対照群で0.92日(0.79~1.86)であった(ハザード比1.05、95%信頼区間0.82~1.33、p=0.72)。

解釈

入院したHIV感染者を対象としたスクリーニング戦略の拡大は、微生物学的に結核と確定診断された患者のうち治療を開始する人の割合を増加させず、8週間後の死亡率を低下させることもなかった。

Ref. New CDC Director Lancet_2026.08

www.thelancet.com

World Report Volume 408, Issue 10557 p775-776 August 29, 2026


New CDC Director promises to protect vaccines and support the agency's “exhausted” scientists
Susan Jaffe

A week after Erica Schwartz took the helm at the beleaguered US Centers for Disease Control and Prevention (CDC) on Aug 12, she convened an all-staff meeting. Schwartz fielded questions from staff and pledged to advocate for the agency, which has been gutted through the loss of thousands of workers and steep funding cuts. She assured staff that she would not hesitate to disagree with her boss, Robert F Kennedy Jr, Secretary of the Department of Health and Human Services, who has presided over the reorganisation.

 

 

 

It recommends that seven immunisations be eliminated from the childhood vaccine schedule and the combined measles, mumps, and rubella (MMR) vaccine should be separated and administered in three separate medical visits. 

 

Schwartz should not wait for the taskforce to meet, Houry said. “She can speak now to the evidence (100 peer countries do not separate the MMR vaccine and Japan, which removed the mumps component, has moved towards putting it back) and the unintended consequences that will result in harm to children with delayed vaccinations.”

 

Ref. US opioid crisis Lancet_2026.08

Lessons from the 1970s for today's US opioid crisis - The Lancet

 

erspectives Book Volume 408, Issue 10556 p686-687 August 22, 2026

Lessons from the 1970s for today's US opioid crisis
Richard J Baum Send email to rjb83@georgetown.edu

 

 

確かに、薬物供給は進化を続けており、ニタゼン類やオルフィン類といった新しい種類の合成オピオイドが現在密売されており、今日の多剤併用はオピオイド依存症の効果的な治療をより複雑にしている。しかしながら、ダフトンが書いている1970年代初頭の連邦政府資金による全国的な薬物治療プログラムは、オピオイドアゴニスト薬と支援的な医療・社会サービスを組み合わせることで、治療成功率に大きな違いが生じることを教えてくれた。現在、オピオイド使用障害を抱えるアメリカ人の多くが、こうした治療を受け始めている。このことに気づくまでに50年もかかったのは残念なことだ。さらに、こうしたサービスから恩恵を受けることができるにもかかわらず、まだ支援を受けていない人々が数多くいる。継続的な進歩は、政府がオピオイド治療プログラムへの投資を減らすのではなく増やすことにかかっている。これらのプログラムには、ニクソン大統領が何年も前に初めて広く利用できるようにしたメサドンを含む薬物を提供する。

Ref. anti-gay law in Senegal

HIV care suffers under Senegal anti-gay law - The Lancet

World Report Volume 408, Issue 10554 p505 August 08, 2026

 

The introduction of harsh penalties for same-sex relations has created a climate of fear that is severely disrupting HIV services. 

 

Patients have been left living in fear and others have gone to neighbouring countries such as The Gambia and Morocco. 

 

Community health workers who were engaged in HIV testing, treatment, and prevention services, such as distribution of condoms, HIV-preventive pre-exposure prophylaxis (PrEP) medication, and monitoring patients, have been arrested. “The laws are incompatible with public health and human rights. Decriminalisation, competent and adequate health services, and measures against stigma and discrimination are the only sustainable ways out”, he said.

 

Senegal's HIV response has already been weakened by US funding cuts on international assistance that came into force in January, 2025. The HIV prevalence among men who have sex with men is estimated to be 27·6%, compared with 0·5% in the general population.

 

“Denying people health rights, regardless of their behaviour, drives people underground and does not improve public health”, Beyrer told The Lancet.